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Abstract 
Background: Ethiopia is one of the countries that are highly affected by dual epidemics of human immunodefi-
ciency virus (HIV) and tuberculosis (TB). HIV infection is a known risk factor for the development of active TB and 
it challenges in diagnosis and treatment of TB. Thus, it is essential to determine the epidemiology of HIV infection 
among TB patients to guide clinical actions and inform the policy makers. This study was aimed to assess the preva-
lence of HIV infection among TB patients and to describe the associated risk factors for HIV seropositivity.
Methods: A retrospective study was conducted on TB registries at Metema Hospital directly observed therapy short-
course (DOTS) clinic. Binary and multivariate logistic regression analysis was used to determine the association of HIV 
seropositivity among TB patients. Odds ratio (OR) and 95 % confidence intervals (CI) were calculated. P value less than 
0.05 was considered as statistically significant.
Results: Of the total 2096 pateints, 2005 (95.7 %) were tested for HIV. The overall HIV–TB co-infection rate was 20.1 % 
(404), 12.3 % (246) in males and 7.9 % (158) in females. The highest proportion of co-infection rate was observed 
among the patients in the age group of 25–34 years (32.4 %) and smear negative pulmonary TB patients (59.7 %). A 
declining trend of HIV–TB co-infection was observed during the study period, from 22.1 % (185) in 2009/10 to 12.8 % 
(52) in 2011/12 (X2 = 17.07, P < 0.001).
Conclusions: This study found that HIV–TB co-infection is still high in the Metema area; and occurs more frequently 
in males than females, and among patients in age group of 25–34 years. Thus, concerted efforts and interventions 
methods that target these at risk groups are recommended.
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Background
Since the late 1980s following the human immunode-
ficiency virus (HIV) pandemic, tuberculosis (TB) has 
re-emerged as an important public health concern in 
the world. TB is the second largest killer of mankind of 
all infectious diseases following HIV/AIDS and it is the 
leading causes of death among HIV-infected patients 
[1]. The latest estimates of the World Health Organiza-
tion (WHO) showed that TB is responsible for 9.0 mil-
lion new cases and about 1.5 million deaths worldwide, of 
which, 360,000 deaths were among HIV positive people 
[2, 3]. A disproportionately large dual TB-HIV epidemic 
still exists in sub-Saharan Africa, accounting for about 
80 % of the estimated global burden in 2013 [3].
HIV infection has been reported to associate with 
an increased risk of developing active TB by facilitat-
ing disease progression during primary TB infections 
or reactivation of latent infection [4–6]. Compared 
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to HIV-uninfected people, for instance, HIV-infected 
people have been reported to be at about 35–40 times 
higher risk of developing active TB in newly acquired 
infection [7, 8]; and at about 20–30 times higher likeli-
hood of reactivating latent infection [5, 6]. Further, HIV 
infection associates with atypical clinical presentation 
of TB including smear negative pulmonary TB, normal 
chest X-ray and higher frequency of extra-pulmonary 
TB (EPTB); thus, challenging TB diagnosis in middle 
and low-income countries [9]. Tuberculosis, on the other 
hand, associates with a chronic immune reactivation that 
increases the risk of HIV progression and death [10]. 
Thus, it is imperative to determine the prevalence of HIV 
infection among TB patients for proper clinical manage-
ments of both infections.
Ethiopia is one of the countries that are highly affected 
by dual epidemics of TB and HIV. In 2013, the preva-
lence and incidence rate of all forms of TB were 211 and 
224 per 100,000 of the population, respectively [2]. The 
prevalence of TB–HIV co-infection among patients with 
known HIV status was 11  %. These data indicating that 
TB and HIV infections continue to be the major con-
cerns of public health in Ethiopia, despite the country 
has achieved a considerable reduction of incidences and 
mortality resulting from these infections.
The epidemiology of HIV in Ethiopia shows remarkable 
variations with geographic regions, the study population 
and with the study periods. Although data on HIV preva-
lence and the associated risk factors among TB patients 
are documented from different parts of the country, 
information regarding this disease epidemiology from 
the Metema area is lacking [11–14]. Metema is located 
in Northwest Ethiopia on the Ethio-Sudan border. The 
major risk factor for HIV infection in Metema is related 
to the large numbers of seasonal migrant day laborers 
(over 80,000), which are the hardest hit by HIV, working 
in big commercial farms [15, 16]. The other important 
risk factor is that Metema is the center for people who 
cross the border for business and entertainment. This 
has attracted a large numbers of commercial sex work-
ers (CSWs), who anticipate “good business” from local 
and foreign clients, into the town. Further, it had been 
speculated that HIV positive individuals from different 
parts of the country may migrate to the border towns like 
Metema to avoid social stigma surrounding the infection 
in their original residence places. Thus, there is a pressing 
need for continues evaluation of the magnitude of HIV 
infections among TB patients in the Metema area to gen-
erate pragmatic data for policy makers and to guide clini-
cal actions.
To this end, the current study aims to assess the preva-
lence of HIV infection among TB patients who attended 
Metema Hospital, Northwest Ethiopia, and to describe 
associated risk factors for HIV infections.
Methods
Study settings and design
A retrospective study was conducted on TB registries at 
Metema hospital DOTS clinic to determine the preva-
lence of HIV infection and the associated risk factors. 
Metema district is located in North Gondar province of 
the Amhara regional state, 850  km from the country’s 
capital Addis Ababa. The town has a population of about 
119,054 (63,433 male and 55,617 female) [18]. There are 
over 80,000 seasonal migrant workers (exclusively males) 
travelling to Metema for temporary labor; and return to 
their original residence places after 3–6 months of stay 
every year. The town is also noted for its border with 
Sudan, Ethio-Sudan highway, safe overnight truck stop, 
market and trading center, red light district and drinking 
houses, and bus station where porters, drivers, food and 
tea sellers, and most unemployed teen age boys and girls 
interact.
Metema hospital provides services for over 1500 
patient in the Northwest Ethiopia per year. In the DOTS 
clinic, TB patients are treated and monitored as per 
the national tuberculosis and leprosy control program 
(NTLCP) guidelines [17]. There are also TB/HIV col-
laborative activities at the hospital which aim to reduce 
the burden of TB among people living with HIV (PLHIV) 
and to reduce the HIV/AIDS burden among TB patients. 
The activities of the collaborative program includes, (1) 
joint TB/HIV planning for integrated TB and HIV ser-
vices delivery; (2) earlier initiation of ART and Isoniazid 
preventive therapy to prevent TB; (3) HIV testing and 
counselling to presumptive and confirmed TB patients, 
(4) HIV prevention interventions for presumptive and 
confirmed TB patients, and (5) provides cotrimoxazole 
preventive therapy for HIV positive TB patients.
Study population and period
The study population was all TB patients who attended 
the Metema hospital between September 2009 and 
August 2012.
Tuberculosis and HIV diagnosis
Tuberculosis diagnosis were performed by examining 
morning sputum samples with Zeihel–Nielsen staining, 
for the presence of acid fast bacilli (AFB); and/or based 
on chest radiography or physician’s judgement to treat 
patients with full course of anti-tuberculosis chemo-
therapy. Extra-pulmonary tuberculosis cases were deter-
mined based on pathological examination and/or clinical 
symptoms compatible with TB.
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HIV infection was detected according to the national 
algorism for HIV testing. Briefly, sera prepared from 
venous blood/whole blood were screened using a HIV 
(1  +   2) antibody Colloidal Gold (KHB, Shanghai Kehua 
Bio-engineering Co Ltd, China), followed by HIV 1/2 
STAT-PAK® (Chembio Diagnostics, USA) if positive. 
Where the result of STAT-PAK® is discordant with KHB, 
Unigold™ HIV test kit (Trinity Biotech, Ireland), was 
used to determine the result.
Definitions
Smear positive pulmonary TB case: defined as a patient 
who tested AFB positive (AFB+) with one or more ini-
tial sputum smear examination by direct microscopy, or 
AFB+  with one sputum examination and radiographic 
abnormalities consistent with pulmonary TB case.
Smear negative pulmonary TB: when a patient does 
not meet the above criteria for smear positive pulmonary 
case but with at least two sputum smear examinations 
negative for AFB, clinical symptoms suggestive of TB and 
radiographic abnormality consistent with active pulmo-
nary TB, or culture positive but sputum smear negative 
results.
EPTB: was defined as a patient with tuberculosis of 
organs other than lungs with diagnosis based on one cul-
ture-positive specimen, or histological or strong clinical 
evidence consistent with active extra-pulmonary disease, 
followed by a decision by a clinician to treat with a full 
course of anti-tuberculosis chemotherapy.
Data collection
Data were collected from the DOTS registration book 
developed by the NTLCP of Ethiopia. Variables such 
as, age, sex, types of TB (whether pulmonary or extra-
pulmonary), and co-morbidity with HIV/AIDS were 
collected.
Statistical analysis
Data were entered, cleaned and analysed using SPSS ver-
sion 20 statistical package (SPSS, Chicago, IL, USA). Data 
cleaning was performed to check for the consistency and 
completeness of the data set. Data were summarized 
using frequencies and proportions to describe the study 
population in relation to relevant variables. Bivariate and 
multivariate analysis was used to identify significant pre-
dictors. The degree of association between independent 
and dependent variables was assessed using odds ratio 
(OR) with 95 % confidence interval (CI). P value of less 
than 0.05 was considered as statistically significant.
Ethics statement
Ethical approval was obtained from the University of 
Gondar ethical review board. Informed consent was not 
obtained as it was a retrospective study. Patients’ identi-
fying information was kept confidentially.
Results
Characteristics of the study participants
A total of 2096  TB patients were registered at Metema 
Hospital DOTS clinic between September 2009 and 
August 2012. Of these, 1246 (59.4  %) were male and 
850 (40.6  %) were female. The median age (IQR) of the 
patients was 28  years (17.00). Six hundred thirty-three 
(30.2  %) patients were in the age group of 25–34  year. 
Of the total 2096 TB patients, 1326 (63.3 %) were smear 
negative pulmonary tuberculosis cases, followed by 471 
(22.5  %) smear positive pulmonary tuberculosis and 
299 (14.3  %) extra-pulmonary tuberculosis cases. With 
respect to entry category, about 89.5 % (1876) were new 
TB cases, while 5.6 % (118) and 4.9 % (102) were retreat-
ment and transfer TB cases, respectively (Table 1).
Prevalence of HIV/TB co‑infection and associated risk 
factors
About 95.7 % (2005) of TB patients registered at DOTS 
center of Metema Hospital were tested for HIV, while 
4.3 % (91) were not tested (Fig. 1). The trend of HIV–TB 
Table 1 Socio-demographic and  clinical characteristics 
of  TB patients treated at  Metema Hospital DOTS center, 
Northwest Ethiopia, 2009–2012
PTB pulmonary tuberculosis, EPTB extra-pulmonary tuberculosis
Characteristics Frequency (N) Percentage (%)
Sex
 Male 1246 59.4
 Female 850 40.6
Age
 0–14 254 12.1
 15–24 537 25.6
 25–34 633 30.2
 35–44 394 18.8
 45–54 151 7.2
 55–64 74 3.5
 >65 53 2.5
Type of entry
 New 1876 89.5
 Relapse 115 5.5
 Return after default 1 0.0
 Failure 2 0.1
 Transfer 102 4.9
TB forms
 Smear positive PTB 471 22.5
 Smear negative PTB 1326 63.3
 EPTB 299 14.3
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co-infection across the years is depicted in Table  2. A 
declining trend of HIV–TB co-infection was observed 
during the study period, from 22.1 % (185) in 2009/10 to 
12.8 % (52) in 2011/12 (X2 = 17.07, P < 0.001). The overall 
prevalence of HIV–TB co-infection was 20.1 % (n = 404), 
12.3  % (246) in males and 7.9  % (158) in females. In 
terms of age, the highest proportion of co-infection rate 
was observed among the patients in the age group of 
25–34 years (32.4 %), followed by those in the age group 
of 15–24 years (26.5 %) and 35–44 years (17.1 %). With 
respect to TB forms, smear negative pulmonary TB 
patients constituted the higher proportion of HIV/TB co-
infected patients (59.7 %) (Table 3).
Univariate and multivariable logistic regression analysis 
was performed to identify socio-demographic and clini-
cal predictors for HIV/TB co-infection among the study 
participants (Table 3). The results showed that there was 
no significant association between HIV/TB co-infection, 
and the selected demographic and clinical determinants 
(P > 0.05).
Discussions
The current study found a high rate of HIV infection 
among TB patients registered at Metema hospital DOTS 
center. The finding 20.1  % HIV/TB co-infection rate in 
this study was higher than those reported from India 
(18.86  %), Brazil (19  %), and the national co-infection 
rate (11.0 %) [2, 19, 20]. This data indicating that Metema 
area is among high HIV-prevalent settings, which are 
Fig. 1 A flow chart showing characteristics of TB patients with respect to their HIV status and forms of tuberculosis. TB tuberculosis, PTB+ smear 
positive pulmonary TB, PTB− smear negative pulmonary TB, EPTB extra-pulmonary TB
Table 2 Trends of HIV–TB co-infection at Metema Hospital, 
September 2009–August 2012





2009/2010 185 (22.1) 651 (77.9) 17.07 <0.001
2010/2011 167 (21.9) 596 (78.1)
2011/2012 52 (12.8) 354 (68.2)
Overall 404 (20.1) 1601 (79.9)
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characterized by HIV prevalence of greater than/equal to 
5 % among tuberculosis patients [21]. Yet, the prevalence 
rate observed in this study was lower when compared 
to similar studies from Gondar (67 %), Bahir Dar (25 %) 
and Debre Markos (44  %), Ethiopia [22–24]. The lower 
prevalence of HIV–TB co-infection in Metema could 
be related to a higher proportion of rural dweller in the 
study population due to a relatively small size of the town 
compared to the above mentioned cities.
In this study, HIV–TB co-infection rate was slightly 
higher in male patients than females. This finding is 
inconsistent with a number of studies that showed 
females to be more prone to HIV infection than their 
male counterparts [25–27]. This discrepancy between 
our finding and others could be plausibly explained 
by the fact that more male daily laborers than females 
migrate to the Metema area and may display risky sexual 
behavior. However, thorough and careful investigations 
are required to identify the contributing factors for such 
discrepancies. A high rate of HIV–TB co-infection was 
also noted in the age group of 25–34 years (32.4 %) and 
among smear negative pulmonary TB patients (59.7  %). 
These were in line with a number of previous studies that 
reported similar findings [28, 29].
Our study revealed that there was a declining trend of 
HIV prevalence among TB patients which is in agree-
ment with the national HIV prevalence trend. This could 
be attributed to the expansion of health education on 
HIV as well as TB prevention and control in the area 
via deployment of health extension worker. However, 
given that we have analysed the trend of only 3 years, 
we recommend further investigations which incorporate 
HIV–TB co-infection data of several years before a firm 
conclusion is drawn.
This study has some limitations including lack of inclu-
sions of important variables such as education level, 
economic status, marital status, and CD4 count which 
might affect their status with respect to these infections. 
Despite the limitations, the results of this study pro-
vided a useful data on the prevalence of HIV among TB 
patients at Metema hospital. This finding may have an 
implication for policy makers and TB program managers 
to address the health care need of these vulnerable popu-
lations in this part of Ethiopia.
Table 3 TB patients at Metema Hospital DOTS center, according to HIV-infection status and associated risk factors for co-
infection, Northwest Ethiopia, 2009–2012
COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, PTB+ smear positive pulmonary TB, PTB− smear negative pulmonary TB, EPTB extra-pulmonary 
TB
Characteristics HIV–TB N (%) TB only N (%) OR (95 % CI) P value AOR (95 % CI) P value
Sex
 Male 246 (60.9) 940 (58.7) 1.09 (0.88–1.37) 0.43 1.1 (0.88–1.38) 0.41
 Female 158 (39.1) 661 (41.3) 1.00 – 1.00 –
Age
 0–14 51 (12.6) 188 (11.7) 0.99 (0.68–1.42) 0.94 1.0 (0.69–1.45) 0.99
 15–24 107 (26.5) 409 (25.5) 0.95 (0.71–1.27) 0.73 0.96 (0.72–1.28) 0.77
 25–34 131 (32.4) 476 (29.7) 1.00 – 1.00 –
 35–44 71 (17.6) 307 (19.2) 0.84 (0.61–1.16) 0.29 0.85 (0.61–1.18) 0.32
 45–54 22 (5.4) 122 (7.6) 0.66 (0.40–1.07) 0.09 0.66 (0.40–1.08) 0.10
 55–64 13 (3.2) 57 (3.6) 0.83 (0.44–1.56) 0.56 0.83 (0.44–1.57) 0.57
 >65 9 (2.2) 42 (2.6) 0.78 (0.37–1.64) 0.51 0.77 (0.36–1.62) 0.49
Type of entry
 New 350 (86.6) 1448 (90.4) 1.00 – 1.00 –
 Relapse 28 (6.9) 81 (5.1) 1.43 (0.92–2.23) 0.12 1.31 (0.82–2.07) 0.26
 Defaulter 0 (0.0) 1 (0.1) – – – –
 Failure 1 (0.2) 1 (0.1) 4.14 (0.26–66.31) 0.32 4.22 (0.26–68.64) 0.31
 Transfer 25 (6.2) 70 (4.4) 1.48 (0.92–2.36) 0.11 1.41 (0.87–2.29) 0.17
TB forms
 PTB+ 105 (26.0) 345 (21.5) 1.00 – 1.00 –
 PTB− 241 (59.7) 1030 (64.3) 1.19 (0.83–1.70) 0.36 1.19 (0.82–1.72) 0.37
 EPTB 58 (14.4) 226 (14.1) 0.91 (0.66–1.26) 0.57 0.97 (0.70–1.35) 0.85
 Total 404 (20.1) 1601 (79.9) – – – –
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Conclusions
This study found that HIV–TB co-infection is still high 
in the Metema area; and occurs more frequently in 
males than females, and among patients in age group 
of 25–34  years. Thus, concerted efforts and inter-
ventions methods that target these at risk groups are 
recommended.
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